Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A8704 StiripentolTarget: Lactate Dehydrogenases (LDH)Summary: An LDH inhibitor
-
A8703 IsosafroleTarget: Lactate Dehydrogenases (LDH)Summary: A stiripentol analog, a potent LDH inhibitor.
-
A4333 CPI-6131 CitationTarget: Pyruvate dehydrogenases (PDH)Summary: PDH/α-KGDH inhibitor
-
A4336 Mycophenolate MofetilSummary: IMPDH inhibitor
-
A4339 AGI-51981 CitationSummary: IDH1 inhibitor against R132 mutant,selective and cell-permeable
-
A4342 GimeracilSummary: Dihydropyrimidine dehydrogenase inhibitor
-
A4348 TrilostaneSummary: 3β-HSD inhibitor
-
A4351 PluriSIn #1 (NSC 14613)Target: Stearoyl-CoA 9-desaturase (SCD-1)Summary: SCD1 inhibitor
-
A3146 AGI-6780Target: IDH2Summary: IDH2/R140Q mutation inhibitor
-
B6104 BVT 2733Summary: 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor